Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.
about
Melphalan hydrochloride for the treatment of multiple myeloma.Autologous transplant for myeloma: when the old meets the new.From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.
P2860
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Autologous transplant vs oral ...... a patients: a pooled analysis.
@en
Autologous transplant vs oral ...... a patients: a pooled analysis.
@nl
type
label
Autologous transplant vs oral ...... a patients: a pooled analysis.
@en
Autologous transplant vs oral ...... a patients: a pooled analysis.
@nl
prefLabel
Autologous transplant vs oral ...... a patients: a pooled analysis.
@en
Autologous transplant vs oral ...... a patients: a pooled analysis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Autologous transplant vs oral ...... ma patients: a pooled analysis
@en
P2093
A Evangelista
A M Carella
A M Liberati
A Malfitano
A P Falcone
C Conticello
P2860
P2888
P304
P356
10.1038/LEU.2016.381
P577
2016-12-23T00:00:00Z